Extracellular vesicles, also known as exosomes, are gaining attention as powerful tools for drug delivery and cell-to-cell communication. In this work. Researchers at Northeastern University, China discuss how plant-derived exosome-like nanoparticles can be used to influence the tumor microenvironment and improve cancer treatment.
The tumor microenvironment includes cancer cells along with surrounding immune cells, blood vessels, and structural components that support tumor growth. When this environment becomes unbalanced, it can promote cancer progression and reduce the effectiveness of therapies such as immunotherapy and antiangiogenic drugs.
Plant-derived extracellular vesicles offer a unique approach because they can carry a wide range of molecules, including proteins, RNA, and small compounds. These vesicles are naturally biocompatible and can interact with human cells through cross-kingdom communication, meaning signals can be transferred between plant-derived particles and human tissues.
Research highlighted here shows that these vesicles can help reprogram the tumor microenvironment by affecting multiple pathways at once. They can alter immune cell behavior, reduce inflammation that supports tumor growth, and directly inhibit cancer cell activity. This multipathway approach makes them particularly attractive as a therapeutic platform.
In addition, plant-derived extracellular vesicles can be engineered or loaded with therapeutic molecules, allowing them to act as targeted delivery systems. This could improve how drugs reach tumors while minimizing side effects.
Despite their promise, there are still challenges to overcome. These include standardizing how the vesicles are isolated and characterized, ensuring consistent quality, and addressing regulatory considerations for clinical use.
Overall, plant-derived extracellular vesicles represent an emerging and versatile strategy for cancer therapy. By targeting the tumor microenvironment in multiple ways, they may help improve treatment outcomes and expand the range of available therapeutic options.
Exosome RNA Exosome RNA Research & Industry News


